Exhaled NO and pulmonary function in children with inflammatory bowel diseases

J. Peradzynska, J. Lange, K. Krenke, I. Lazowska, A. Banaszkiewicz, M. Kulus, P. Albrecht, A. Radzikowski (Warsaw, Poland)

Source: Annual Congress 2007 - Clinical outcome studies and technical aspects of paediatric lung function testing
Session: Clinical outcome studies and technical aspects of paediatric lung function testing
Session type: Electronic Poster Discussion
Number: 1435
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Peradzynska, J. Lange, K. Krenke, I. Lazowska, A. Banaszkiewicz, M. Kulus, P. Albrecht, A. Radzikowski (Warsaw, Poland). Exhaled NO and pulmonary function in children with inflammatory bowel diseases. Eur Respir J 2007; 30: Suppl. 51, 1435

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The concentration of inflammatory cytokines in exhaled breath condensate in children with inflammatory bowel diseases
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011

Lung function in children with inflammatory bowel diseases
Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases
Year: 2007


Exhaled hydrogen sulfide in patients with chronic airway inflammatory disease
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011

Exhaled nitric oxide in respiratory diseases other than asthma
Source: Eur Respir Monogr 2010; 49: 45-55
Year: 2010


Exhaled markers in the monitoring of airways inflammation in mild persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 679s
Year: 2004

Bronchial hyperreactivity in patients with inflammatory bowel disease
Source: Eur Respir J 2003; 22: Suppl. 45, 480s
Year: 2003

Clinically relevant early functional and diagnostic markers of lung disease in children
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120
Year: 2006

Exhaled NO, small airway obstruction and airway hyper-responsiveness in pediatric asthma
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010


Airway and lung involvement in inflammatory bowel disease
Source: Eur Respir Monogr 2019; 86: 228-261
Year: 2019


Pulmonary involvement of inflammatory bowel disease in children and adult patients
Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders
Year: 2010


Measurement of exhaled gases in chronic airway diseases
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017


Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005

Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases
Source: Annual Congress 2009 - Lung function in adults and children
Year: 2009


Exhaled 8-isoprostane as a marker of airway inflammation in asthmatic children
Source: Eur Respir J 2001; 18: Suppl. 33, 39s
Year: 2001

Exhaled nitric oxide in diagnosis and management of respiratory diseases
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013


Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013


Exhaled breath condensate markers in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005

Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019

Increased incidence of inflammatory bowel disease in Québec residents with airway diseases
Source: Eur Respir J 2015; 45: 962-968
Year: 2015



Differential assessment of airway inflammation in chronic obstructive pulmonary disease (COPD) by measurements of exhaled nitric oxide (NO) derived from peripheral vs. central airways
Source: Eur Respir J 2003; 22: Suppl. 45, 279s
Year: 2003